 | Up a level |
Dreyling, Martin; Doorduijn, Jeanette; Giné, Eva; Jerkeman, Mats; Walewski, Jan; Hutchings, Martin; Mey, Ulrich; Riise, Jon; Trneny, Marek; Vergote, Vibeke; Shpilberg, Ofer; Gomes da Silva, Maria; Leppä, Sirpa; Jiang, Linmiao; Stilgenbauer, Stephan; Kerkhoff, Andrea; Jachimowicz, Ron D; Celli, Melania; Hess, Georg; Arcaini, Luca; ... (2024). Ibrutinib combined with immunochemotherapy with or without autologous stem-cell transplantation versus immunochemotherapy and autologous stem-cell transplantation in previously untreated patients with mantle cell lymphoma (TRIANGLE): a three-arm, randomised, open-label, phase 3 superiority trial of the European Mantle Cell Lymphoma Network. The lancet, 403(10441), pp. 2293-2306. Elsevier 10.1016/S0140-6736(24)00184-3
Berning, Philipp; Shumilov, Evgenii; Maulhardt, Markus; Boyadzhiev, Hristo; Kerkhoff, Andrea; Call, Simon; Reicherts, Christian; Saidy, Anna O.; Aydilek, Enver; Hoffmann, Michèle; Novak, Urban; Daskalakis, Michael; Schmitz, Norbert; Stelljes, Matthias; Wulf, Gerald; Bacher, Ulrike; Lenz, Georg; Pabst, Thomas Niklaus (2024). Chimeric antigen receptor-T cell therapy shows similar efficacy and toxicity in patients with diffuse large B-cell lymphoma aged 70 and older compared to younger patients: A multicenter cohort study. HemaSphere, 8(3), pp. 1-12. Wiley 10.1002/hem3.54
Mandhair, Harpreet K; Radpour, Ramin; Westerhuis, Mira; Banz, Yara; Humbert, Magali; Arambasic, Miroslav; Dengjel, Jörn; Davies, Andrew; Tschan, Mario P; Novak, Urban (2024). Analysis of autophagy in DLBCL reveals subtype-specific differences and the preferential targeting of ULK1 inhibition in GCB-DLBCL provides a rationale as a new therapeutic approach. Leukemia, 38(2), pp. 424-429. Nature Publishing Group 10.1038/s41375-024-02147-4
de Ramon Ortiz, Carmen; Wang, Sisi; Stathis, Anastasios; Bertoni, Francesco; Zenz, Thorsten; Novak, Urban; Simonetta, Federico (2024). How to integrate CD19 specific chimeric antigen receptor T cells with other CD19 targeting agents in diffuse large B-cell lymphoma? Hematological oncology, 42(1), e3237. Wiley 10.1002/hon.3237
Passweg, Jakob R; Baldomero, Helen; Ansari, Marc; Arber, Caroline; Chalandon, Yves; Daskalakis, Michael; Diepold, Miriam; Diesch-Furlanetto, Tamara; Duchosal, Michel A; Gerull, Sabine; Güngör, Tayfun; Heim, Dominik; Hitz, Felicitas; Holbro, Andreas; Masouridi-Levrat, Stavroula; Nair, Gayathri; Novak, Urban; Pabst, Thomas; Renner, Christoph; Stussi, Georg; ... (2024). Hematopoietic cell transplantation and cellular therapies in Switzerland. Evolution over 25 years. A report from the stem cell transplantation and cellular therapies working groups of the SBST 1997-2021. Hematological oncology, 42(1), e3241. Wiley 10.1002/hon.3241
Chamuleau, Martine E D; Stenner, Frank; Chitu, Dana A; Novak, Urban; Minnema, Monique C; Geerts, Paul; Stevens, Wendy B C; Zenz, Thorsten; van Imhoff, Gustaaf W; Wu, Ka Lung; Demandt, Astrid M P; Kersten, Marie Jose; Terpstra, Wim E; Tick, Lidwine W; Deeren, Dries; Van Den Neste, Eric; Gregor, Michael; Veelken, Hendrik; Böhmer, Lara H; Caspar, Clemens B; ... (2023). R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON/SAKK): final results of a multicentre, phase 3, open-label, randomised trial. The Lancet. Haematology, 10(12), e966-e975. Elsevier 10.1016/S2352-3026(23)00279-X
Shumilov, Evgenii; Boyadzhiev, Hristo; Mazzeo, Paolo; Akhoundova, Dilara; Daskalakis, Michael; Novak, Urban; Lenz, Georg; Bacher, Ulrike; Pabst, Thomas (2023). CAR-T Cell Therapy Shows Similar Efficacy and Toxicity in Patients With DLBCL Regardless of CNS Involvement. HemaSphere, 7(12), e984. Wolters Kluwer Health 10.1097/HS9.0000000000000984
Novak, Urban; Fehr, Martin; Schär, Sämi; Dreyling, Martin; Schmidt, Christian; Derenzini, Enrico; Zander, Thilo; Hess, Georg; Mey, Ulrich; Ferrero, Simone; Mach, Nicolas; Boccomini, Carola; Böttcher, Sebastian; Voegeli, Michèle; Cairoli, Anne; Ivanova, Vanesa-Sindi; Menter, Thomas; Dirnhofer, Stefan; Scheibe, Bernhard; Gadient, Sandra; ... (2023). Combined therapy with ibrutinib and bortezomib followed by ibrutinib maintenance in relapsed or refractory mantle cell lymphoma and high-risk features: a phase 1/2 trial of the European MCL network (SAKK 36/13). EClinicalMedicine, 64, p. 102221. Elsevier 10.1016/j.eclinm.2023.102221
Messerli, Christian; Wiedemann, Gertrud; Porret, Naomi; Nagler, Michael; Seipel, Katja; Jeker, Barbara; Novak, Urban; Zeerleder, Sacha; Bacher, Ulrike; Pabst, Thomas (2023). Correlation of peripheral chimeric antigen receptor T-cell (CAR-T cell) mRNA expression levels with toxicities and outcome in patients with diffuse large B-cell lymphoma (DLBCL). Turkish journal of haematology, 40(3), pp. 187-196. Turkish Society of Haematology 10.4274/tjh.galenos.2023.2023.0136
Wahli, Murielle N; Hayoz, Stefanie; Hoch, Dennis; Ryser, Christoph O; Hoffmann, Michèle; Scherz, Amina; Schwacha-Eipper, Birgit; Häfliger, Simon; Wampfler, Julian; Berger, Martin D; Novak, Urban; Özdemir, Berna C (2023). The role of immune checkpoint inhibitors in clinical practice: an analysis of the treatment patterns, survival and toxicity rates by sex. Journal of cancer research and clinical oncology, 149(7), pp. 3847-3858. Springer 10.1007/s00432-022-04309-2
Davies, Andrew J; Barrans, Sharon; Stanton, Louise; Caddy, Josh; Wilding, Sam; Saunders, Geoff; Mamot, Christoph; Novak, Urban; McMillan, Andrew; Fields, Paul; Collins, Graham P; Stephens, Richard; Cucco, Francesco; Sha, Chulin; van Hoppe, Moniek; Tooze, Reuben; Davies, John R; Griffiths, Gareth; Schuh, Anna; Burton, Catherine; ... (2023). Differential Efficacy From the Addition of Bortezomib to R-CHOP in Diffuse Large B-Cell Lymphoma According to the Molecular Subgroup in the REMoDL-B Study With a 5-Year Follow-Up. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 41(15), pp. 2718-2723. American Society of Clinical Oncology 10.1200/JCO.23.00033
von Matt, Stefanie; Bacher, Ulrike; Banz, Yara; Mansouri Taleghani, Behrouz; Novak, Urban; Pabst, Thomas (2023). Outcome of Patients with Diffuse Large B-Cell Lymphoma Relapsing after Autologous Transplant before Availability of CAR-T Cell Treatment. Mediterranean journal of hematology and infectious diseases, 15(1), e2023025. Università Cattolica del Sacro Cuore 10.4084/MJHID.2023.025
Penack, Olaf; Peczynski, Christophe; Koenecke, Christian; Polge, Emmanuelle; Kuhnl, Andrea; Fegueux, Nathalie; Daskalakis, Michael; Kröger, Nicolaus; Dreger, Peter; Besley, Caroline; Schanz, Urs; Bloor, Adrian; Ganser, Arnold; Forcade, Edouard; Corral, Lucia López; Passweg, Jakob R; Novak, Urban; Moiseev, Ivan; Schoemans, Hélène; Basak, Grzegorz W; ... (2023). Severe cytopenia after CD19 CAR T-cell therapy: a retrospective study from the EBMT Transplant Complications Working Party. Journal for immunotherapy of cancer, 11(4) BMJ Publishing Group 10.1136/jitc-2022-006406
Huwyler, Fabrizio; Kunz, Rebekka; Bacher, Ulrike; Hoffmann, Michèle; Novak, Urban; Daskalakis, Michael; Banz, Yara; Pabst, Thomas (2023). Evaluation of Bortezomib-BeEAM (2BeEAM) as Chemotherapy Regimen Prior to ASCT in Patients with Mantle Cell Lymphoma. Cancers, 15(7) MDPI AG 10.3390/cancers15072091
Mamot, Christoph; Wicki, Andreas; Hasler-Strub, Ursula; Riniker, Salome; Li, Qiyu; Holer, Lisa; Bärtschi, Daniela; Zaman, Khalil; von Moos, Roger; Dedes, Konstantin J; Boos, Laura A; Novak, Urban; Bodmer, Alexandre; Ritschard, Reto; Obermann, Ellen C; Tzankov, Alexandar; Ackermann, Christoph; Membrez-Antonioli, Véronique; Zürrer-Härdi, Ursina; Caspar, Clemens B; ... (2023). A multicenter phase II trial of anti-EGFR-immunoliposomes loaded with doxorubicin in patients with advanced triple negative breast cancer. Scientific Reports, 13(1), p. 3705. Nature Publishing Group 10.1038/s41598-023-30950-z
Novak, Urban; Žerovnik, Eva; Taler-Verčič, Ajda; Žnidarič, MagdaTušek; Zupančič, Barbara; Grdadolnik, Jože (2023). Amyloid Formation of Stefin B Protein Studied by Infrared Spectroscopy. Frontiers in bioscience (Landmark edition), 28(3), p. 46. IMR Press 10.31083/j.fbl2803046
Zander, Thilo; Pabst, Thomas; Schär, Sämi; Aebi, Stefan; Mey, Ulrich; Novak, Urban; Lerch, Erika; Rhyner Agocs, Gaëlle; Goede, Jeroen; Maniecka, Zuzanna; Hayoz, Stefanie; Rüfer, Axel; Renner, Christoph; Driessen, Christoph (2023). Alternate-day dosing of pomalidomide in relapsed/ refractory multiple myeloma: a multicenter, single-arm phase 2 trial. Leukemia, 37(3), pp. 699-701. Springer Nature 10.1038/s41375-023-01809-z
Jeran, Marko; Romolo, Anna; Spasovski, Vesna; Hočevar, Matej; Novak, Urban; Štukelj, Roman; Šuštar, Vid; Kisovec, Matic; Bedina Zavec, Apolonija; Kogej, Ksenija; Iglič, Aleš; Trebše, Polonca; Kralj-Iglič, Veronika (2023). Small Cellular Particles from European Spruce Needle Homogenate. International journal of molecular sciences, 24(5) MDPI 10.3390/ijms24054349
Lang, Noémie; Novak, Urban (2023). Numerous Hot Topics in Lymphoproliferative Disorders. Leading opinions - Hämatologie und Onkologie Universimed
Lakomy, Tim; Akhoundova, Dilara; Nilius, Henning; Kronig, Marie-Noëlle; Novak, Urban; Daskalakis, Michael; Bacher, Ulrike; Pabst, Thomas (2023). Early Use of Corticosteroids following CAR T-Cell Therapy Correlates with Reduced Risk of High-Grade CRS without Negative Impact on Neurotoxicity or Treatment Outcome. Biomolecules, 13(2) MDPI 10.3390/biom13020382
Paoletti, Francesca; Covaceuszach, Sonia; Cassetta, Alberto; Calabrese, Antonio N; Novak, Urban; Konarev, Petr; Grdadolnik, Jože; Lamba, Doriano; Golič Grdadolnik, Simona (2023). Distinct conformational changes occur within the intrinsically unstructured pro-domain of pro-Nerve Growth Factor in the presence of ATP and Mg2. Protein science, 32(2), e4563. Wiley-Blackwell 10.1002/pro.4563
Hitz, Felicitas; Lang, Noémie; Mey, Ulrich; Mingrone, Walter; Moccia, Alden; Taverna, Christian; Novak, Urban; Stenner, Frank; Schmidt, Adrian; Mamot, Christoph; Fischer, Natalie; Putora, Paul M (2023). Decision-making among experts in advanced Hodgkin Lymphoma. Oncology, 101(3), pp. 159-165. Karger 10.1159/000526360
Penack, Olaf; Peczynski, Christophe; Koenecke, Christian; Polge, Emmanuelle; Sanderson, Robin; Yakoub-Agha, Ibrahim; Fegueux, Nathalie; Daskalakis, Michael; Collin, Matthew; Dreger, Peter; Kröger, Nicolaus; Schanz, Urs; Bloor, Adrian; Ganser, Arnold; Besley, Caroline; Wulf, Gerald G; Novak, Urban; Moiseev, Ivan; Schoemans, Hélène; Basak, Grzegorz W; ... (2023). Organ complications after CD19 CAR T-cell therapy for large B cell lymphoma: a retrospective study from the EBMT transplant complications and lymphoma working party. Frontiers in immunology, 14, p. 1252811. Frontiers Research Foundation 10.3389/fimmu.2023.1252811
Dislich, Bastian; Hoch, Dennis; Dirnhofer, Stefan; Novak, Urban; Banz, Yara (2022). An unusual pseudolymphoma in the context of necrotizing fasciitis: A case report. Medicine, 101(51), e32457. Wolters Kluwer Health 10.1097/MD.0000000000032457
Heini, Alexander D; Bacher, Ulrike; Porret, Naomi; Wiedemann, Gertrud; Legros, Myriam; Stalder Zeerleder, Denise; Seipel, Katja; Novak, Urban; Daskalakis, Michael; Pabst, Thomas (2022). Experiences with Glofitamab Administration following CAR T Therapy in Patients with Relapsed Mantle Cell Lymphoma. Cells, 11(17) MDPI 10.3390/cells11172747
Gössi, Simona; Bacher, Ulrike; Haslebacher, Claudia; Nagler, Michael; Suter, Franziska; Staehelin, Cornelia; Novak, Urban; Pabst, Thomas (2022). Humoral Responses to Repetitive Doses of COVID-19 mRNA Vaccines in Patients with CAR-T-Cell Therapy. Cancers, 14(14) MDPI AG 10.3390/cancers14143527
Stathis, Anastasios; Mey, Ulrich J M; Schär, Sämi; Hitz, Felicitas; Pott, Christiane; Mach, Nicolas; Krasniqi, Fatime; Novak, Urban; Schmidt, Christian; Hohloch, Karin; Kienle, Dirk Lars; Hess, Dagmar; Moccia, Alden A; Unterhalt, Michael; Eckhardt, Katrin; Hayoz, Stefanie; Forestieri, Gabriela; Rossi, Davide; Dirnhofer, Stefan; Ceriani, Luca; ... (2022). SAKK 35/15: a phase 1 trial of obinutuzumab in combination with venetoclax in patients with previously untreated follicular lymphoma. Blood advances, 6(13), pp. 3911-3920. American Society of Hematology 10.1182/bloodadvances.2021006520
Stoffel, Tanja; Bacher, Ulrike; Banz, Yara; Daskalakis, Michael; Novak, Urban; Pabst, Thomas (2022). BeEAM High-Dose Chemotherapy with Polatuzumab (Pola-BeEAM) before ASCT in Patients with DLBCL-A Pilot Study. Journal of clinical medicine, 11(13) MDPI 10.3390/jcm11133748
Heini, Alexander D; Bacher, Ulrike; Kronig, Marie-Noëlle; Wiedemann, Gertrud; Novak, Urban; Zeerleder, Sacha; Mansouri Taleghani, Behrouz; Daskalakis, Michael; Pabst, Thomas (2022). Chimeric antigen receptor T-cell therapy for relapsed mantle cell lymphoma: real-world experience from a single tertiary care center. Bone marrow transplantation, 57(6), pp. 1010-1012. Springer Nature 10.1038/s41409-022-01658-x
Bertschinger, Martina; Novak, Urban (June 2022). Spannende Daten zu aggressiven Lymphomen. Leading Opinions. Hämatologie & Onkologie(5), pp. 6-8. Universimed
Novak, Urban; Golobič, Amalija; Klančnik, Natalija; Mohaček-Grošev, Vlasta; Stare, Jernej; Grdadolnik, Jože (2022). Strong Hydrogen Bonds in Acetylenedicarboxylic Acid Dihydrate. International journal of molecular sciences, 23(11) MDPI 10.3390/ijms23116164
Schmitt, Andreas Michael; Walter, Martin; Herbrand, Amanda Katherina; Jörger, Markus; Moffa, Giusi; Novak, Urban; Hemkens, Lars; Kasenda, Benjamin (2022). Characteristics and survival of patients with cancer with intended off-label use-a cohort study. BMJ open, 12(5), e060453. BMJ Publishing Group 10.1136/bmjopen-2021-060453
Mathys, Anina; Bacher, Ulrike; Banz, Yara; Legros, Myriam; Mansouri Taleghani, Behrouz; Novak, Urban; Pabst, Thomas (2022). Outcome of patients with mantle cell lymphoma after autologous stem cell transplantation in the pre-CAR T-cell era Letter. Hematological oncology, 40(2), pp. 292-296. Wiley 10.1002/hon.2952
Novak, U (March 2022). CD19-gerichtete CAR-T-Zell-Therapie in der Schweiz: der klinische Alltag. Leading Opinions. Hämatologie & Onkologie, pp. 18-20. Universimed
Bonfiglio, Ferdinando; Bruscaggin, Alessio; Guidetti, Francesca; Terzi di Bergamo, Lodovico; Faderl, Martin Richard; Spina, Valeria; Condoluci, Adalgisa; Bonomini, Luisella; Forestieri, Gabriela; Koch, Ricardo; Piffaretti, Deborah; Pini, Katia; Pirosa, Maria C; Cittone, Micol Giulia; Arribas, Alberto; Lucioni, Marco; Ghilardi, Guido; Wu, Wei; Arcaini, Luca; Baptista, Maria Joao; ... (2022). Genetic and Phenotypic Attributes of Splenic Marginal Zone Lymphoma. Blood, 139(5), pp. 732-747. American Society of Hematology 10.1182/blood.2021012386
Shumilov, Evgenii; Mazzeo, Paolo; Zinkernagel, Martin S.; Legros, Myriam; Porret, Naomi; Romagna, Lorenz; Haase, Detlef; Lenz, Georg; Novak, Urban; Banz, Yara; Pabst, Thomas; Bacher, Vera (2022). Comprehensive Laboratory Diagnostic Workup for Patients with Suspected Intraocular Lymphoma including Flow Cytometry, Molecular Genetics and Cytopathology. Current oncology, 29(2), pp. 766-776. MDPI 10.3390/curroncol29020065
Pirosa, Maria C; Zhang, Lu; Hitz, Felicitas; Novak, Urban; Hess, Dagmar; Terrot, Tatiana; Pascale, Mariarosa; Mazzucchelli, Luca; Bertoni, Francesco; Cavalli, Franco; Zucca, Emanuele; Stathis, Anastasios (2022). A phase I trial of inotuzumab ozogamicin in combination with temsirolimus in patients with relapsed or refractory CD22-positive B-cell non-Hodgkin lymphomas. Leukemia & lymphoma, 63(1), pp. 117-123. Taylor & Francis 10.1080/10428194.2021.1966780
Messmer, Anna S; Que, Yok-Ai; Schankin, Christoph; Banz, Yara; Bacher, Ulrike; Novak, Urban; Pabst, Thomas (2021). CAR T-cell therapy and critical care : A survival guide for medical emergency teams. Wiener klinische Wochenschrift, 133(23-24), pp. 1318-1325. Springer-Verlag 10.1007/s00508-021-01948-2
Messmer, Anna Sarah; Que, Yok-Ai; Schankin, Christoph; Banz, Yara; Bacher, Ulrike; Novak, Urban; Pabst, Thomas (2021). Novel Adaptive T-Cell Oncological Treatments Lead to New Challenges for Medical Emergency Teams: A 2-Year Experience From a Tertiary-Care Hospital in Switzerland. Critical care explorations, 3(10), e0552. Wolters Kluwer Health 10.1097/CCE.0000000000000552
Berger, Martin D.; Trelle, Sven; Büchi, Annina E.; Jegerlehner, Sabrina; Ionescu, Codruta; Lamy de la Chapelle, Thierry; Novak, Urban (2021). Impact on survival through consolidation radiotherapy for diffuse large B-cell lymphoma: a comprehensive meta-analysis. Haematologica - the hematology journal, 106(7), pp. 1923-1931. Ferrata-Storti Foundation 10.3324/haematol.2020.249680
Mandhair, Harpreet K; Novak, Urban; Radpour, Ramin (2021). Epigenetic regulation of autophagy: A key modification in cancer cells and cancer stem cells. World journal of stem cells, 13(6), pp. 542-567. Baishideng Publishing Group 10.4252/wjsc.v13.i6.542
Novak, Urban; Grdadolnik, Jože (2021). Infrared spectra of hydrogen bond network in lamellar perfluorocarboxylic acid monohydrates. Spectrochimica acta. Part A - molecular and biomolecular spectroscopy, 253, p. 119551. Elsevier 10.1016/j.saa.2021.119551
Moccia, A A; Aeppli, S; Güsewell, S; Bargetzi, M; Caspar, C; Brülisauer, D; Ebnöther, M; Fehr, M; Fischer, N; Ghilardi, G; Krasniqi, F; Lang, N; Mey, U; Mingrone, W; Novak, U; Pfleger, C; Richter, P; Rütti, M; Schmidt, A; Stenner, F; ... (2021). Clinical characteristics and outcome of patients over 60 years with Hodgkin lymphoma treated in Switzerland. Hematological oncology, 39(2), pp. 196-204. Wiley 10.1002/hon.2830
Herbrand, Amanda Katherina; Schmitt, Andreas M; Briel, Matthias; Ewald, Hannah; Goldkuhle, Marius; Diem, Stefan; Hoogkamer, Anouk; Joerger, Markus; Moffa, Giusi; Novak, Urban; Hemkens, Lars G; Kasenda, Benjamin (2021). Association of Supporting Trial Evidence and Reimbursement for Off-Label Use of Cancer Drugs. JAMA network open, 4(3), e210380. American Medical Association 10.1001/jamanetworkopen.2021.0380
Moccia, Alden Alberto; Schär, Sämi; Hayoz, Stefanie; Pirosa, Maria Cristina; Taverna, Christian; Novak, Urban; Kimby, Eva; Ghielmini, Michele; Zucca, Emanuele (2021). Prognostic value of POD24 validation in follicular lymphoma patients initially treated with chemotherapy-free regimens in a pooled analysis of three randomized trials of the Swiss Group for Clinical Cancer Research (SAKK). British journal of haematology, 192(6), pp. 1031-1034. Wiley-Blackwell 10.1111/bjh.17045
Pellegrini, Luca; Novak, Urban; Andres, Martin; Suter, Thomas; Nagler, Michael (2021). Risk of bleeding complications and atrial fibrillation associated with ibrutinib treatment: A systematic review and meta-analysis. Critical reviews in oncology/hematology, 159, p. 103238. Elsevier 10.1016/j.critrevonc.2021.103238
Ferreri, Andrés J M; Doorduijn, Jeanette K; Re, Alessandro; Cabras, Maria Giuseppina; Smith, Jeffery; Ilariucci, Fiorella; Luppi, Mario; Calimeri, Teresa; Cattaneo, Chiara; Khwaja, Jahanzaib; Botto, Barbara; Cellini, Claudia; Nassi, Luca; Linton, Kim; McKay, Pam; Olivieri, Jacopo; Patti, Caterina; Re, Francesca; Fanni, Alessandro; Singh, Vikram; ... (2021). MATRix-RICE therapy and autologous haematopoietic stem-cell transplantation in diffuse large B-cell lymphoma with secondary CNS involvement (MARIETTA): an international, single-arm, phase 2 trial. The Lancet. Haematology, 8(2), e110-e121. Elsevier 10.1016/S2352-3026(20)30366-5
Jeker, Barbara; Daskalakis, Michael; Zeerleder, Sacha; Pabst, Thomas; Novak, Urban (January 2021). CAR T Cells: Immuntherapie mit grossem Potenzial. Onkologie & Hämatologie, 2021, pp. 16-19. Prime Public Media AG
Nydegger, Anna; Novak, Urban; Kronig, Marie-Noëlle; Legros, Myriam; Zeerleder, Sacha; Banz, Yara; Bacher, Ulrike; Pabst, Thomas (2021). Transformed Lymphoma Is Associated with a Favorable Response to CAR-T-Cell Treatment in DLBCL Patients. Cancers, 13(23) MDPI AG 10.3390/cancers13236073
Siegenthaler, Franziska; Imboden, Sara; Lössl, Kristina; Novak, Urban; Dingeldein, Irène; Mueller, Michael (2021). [Diversity of malignant uterine disease]. Swiss Medical Forum ‒ Schweizerisches Medizin-Forum, 2021(17–18), pp. 290-296. EMH Schweizerischer Ärzteverlag 10.4414/smf.2021.08724
Zander, Thilo; Pabst, Thomas; Schär, Sämi; Aebi, Stefan; Pabst, Tobias; Mey, Ulrich; Novak, Urban; Lerch, Erika; Rhyner, Gaëlle; Goede, Jeroen; Maniecka, Zuzanna; Hayoz, Stefanie; Rufer, Axel; Renner, Christoph; Driessen, Christoph (2021). P-227: Alternate day dosing of pomalidomide in patients with refractory/relapsed multiple myeloma (RRMM): Results of a multicenter, single arm phase 2 trial (SAKK 39/16 OptiPOM Study). Clinical lymphoma, myeloma and leukemia, 21(Suppl. 2), S165-S165. Elsevier 10.1016/S2152-2650(21)02354-5
Novak, Urban (2020). CAR-T cell therapy of lymphoma: where do we stand? CAR-T will replace allo-SCT – PRO. Schweizer Krebsbulletin / Bulletin suisse du cancer, 40(4), pp. 295-299. Istituto oncologico della Svizzera Italiana
Jeker, Barbara; Farag, Sarah; Mansouri Taleghani, Behrouz; Novak, Urban; Mueller, Beatrice U; Li, Qiyu; Betticher, Daniel; Luethi, Jean-Marc; Farese, Simone; Ruefer, Axel; Bacher, Ulrike; Pabst, Thomas (2020). A randomized evaluation of vinorelbine versus gemcitabine chemotherapy mobilization of stem cells in myeloma patients. Bone marrow transplantation, 55(10), pp. 2047-2051. Springer Nature 10.1038/s41409-020-0875-8
Benz, Rudolf; Arn, Kornelius; Andres, Martin; Pabst, Thomas; Baumann, Michael; Novak, Urban; Hitz, Felicitas; Hess, Urs; Zenhaeusern, Reinhard; Chalandon, Yves; Mey, Ulrich; Blum, Sabine; Rauch, Daniel; O'Meara Stern, Alix; Cantoni, Nathan; Bargetzi, Mario; Bianchi-Papina, Elena; Rossi, Davide; Passweg, Jakob; Lohri, Andreas; ... (2020). Prospective long-term follow-up after first-line subcutaneous cladribine in hairy cell leukemia: a SAKK trial. Blood advances, 4(15), pp. 3699-3707. American Society of Hematology 10.1182/bloodadvances.2020002160
Sula, Martin; Bacher, Vera; Oppliger Leibundgut, Elisabeth; Mansouri, Behrouz; Novak, Urban; Pabst, Thomas (2020). Excellent outcome after consolidation with autologous transplantation in patients with core binding factor acute myeloid leukemia. Bone marrow transplantation, 55(8), pp. 1690-1693. Springer Nature 10.1038/s41409-019-0762-3
Pabst, Thomas; Joncourt, Raphael; Shumilov, Evgenii; Heini, Alexander; Wiedemann, Gertrud; Legros, Myriam; Seipel, Katja; Schild, Christof; Jalowiec, Katarzyna; Mansouri, Behrouz; Fux, Michaela; Novak, Urban; Porret, Naomi; Zeerleder, Sacha; Bacher, Vera (2020). Analysis of IL-6 serum levels and CAR-T cell specific digital PCR in the context of cytokine release syndrome (CRS). Experimental hematology, 88, 7-14.e3. Elsevier 10.1016/j.exphem.2020.07.003
Novak, Urban (June 2020). Update zur CAR-T-Zell-Therapie. Leading Opinions. Hämatologie & Onkologie, 2020(6), pp. 6-9. Universimed
Mandhair, Harpreet K.; Arambasic, Miroslav; Novak, Urban; Radpour, Ramin (2020). Molecular modulation of autophagy: New venture to target resistant cancer stem cells. World journal of stem cells, 12(5), pp. 303-322. 10.4252/wjsc.v12.i5.303
Flach, Johanna; Shumilov, Evgenii; Joncourt, Raphael; Porret, Naomi; Novak, Urban; Pabst, Thomas; Bacher, Ulrike (2020). Current concepts and future directions for hemato-oncologic diagnostics. Critical reviews in oncology, hematology, 151, p. 102977. Elsevier 10.1016/j.critrevonc.2020.102977
Flach, Johanna; Shumilov, Evgenii; Joncourt, Raphael; Porret, Naomi; Tchinda, Joëlle; Legros, Myriam; Scarpelli, Ilaria; Hewer, Ekkehard; Novak, Urban; Schoumans, Jacqueline; Bacher, Vera; Pabst, Thomas (2020). Detection of rare reciprocal RUNX1 rearrangements by next‐generation sequencing (NGS) in acute myeloid leukemia. Genes, chromosomes & cancer, 59(4), pp. 268-274. Wiley 10.1002/gcc.22829
Bürki, S; Novak, U (2020). Dual Mechanism of Severe Bleeding Diathesis in a Patient with CLL: Acquired Von Willebrand Syndrome and Ibrutinib - Mediated Platelets Dysfunction. Annals of Hematology & Oncology, 7(3) Austin Publishing Group
Heini, Alexander D.; Hugo, Rebecca; Berger, Martin D.; Novak, Urban; Bacher, Ulrike; Pabst, Thomas (2020). A simple acute phase protein score to predict long-term survival in patients with acute myeloid leukemia. Hematological oncology, 38(1), pp. 74-81. Wiley 10.1002/hon.2696
De Santiago de Benito, Alvaro; Jeker, Barbara; Gfeller, Eva; Porret, Naomi; Banz, Yara; Novak, Urban; Bacher, Ulrike; Pabst, Thomas (2020). Molecular minimal residual disease negativity and decreased stem cell mobilization potential predict excellent outcome after autologous transplant in NPM1 mutant acute myeloid leukemia. Haematologica - the hematology journal, 105(1), e9-e12. Ferrata-Storti Foundation 10.3324/haematol.2019.216457
Trachsel, Maria; Wertli, Maria M.; Novak, Urban; Berezowska, Sabina; Pöllinger, Alexander; Wenemoser, Eliane (2020). Ein protrahiertes «fever of unknown origin». Swiss medical forum, 20(43-44), pp. 616-619. EMH Schweizerischer Ärzteverlag AG
Moser, Sebastian; Bacher, Vera Ulrike; Jeker, Barbara; Mansouri Taleghani, Behrouz; Betticher, Daniel; Ruefer, Axel; Egger, Thomas; Novak, Urban; Pabst, Thomas (2019). Autologous stem cell transfusions on multiple days in patients with multiple myeloma ‐ does it matter? Hematological oncology, 37(5), pp. 649-651. Wiley 10.1002/hon.2673
Prediletto, Irene; Farag, Sarah Ahmed Ibrahim; Bacher, Vera Ulrike; Jeker, Barbara; Mansouri Taleghani, Behrouz; Bregy, Rachel; Zander, Thilo; Betticher, Daniel; Egger, Thomas; Novak, Urban; Pabst Müller, Thomas Niklaus (2019). High incidence of reversible renal toxicity of dose-intensified bendamustine-based high-dose chemotherapy in lymphoma and myeloma patients. Bone marrow transplantation, 54(12), pp. 1923-1925. Nature Publishing Group 10.1038/s41409-019-0508-2
Fassbind, Priska; Jeker, Barbara; Müller, Beatrice Ursula; Bacher, Vera Ulrike; Zimmerli, Stefan; Endrich, Olga; Gahl, Brigitta; Novak, Urban; Pabst Müller, Thomas Niklaus (2019). Improved survival rates of AML patients following admission to the intensive care unit. Leukemia & lymphoma, 60(10), pp. 2423-2431. Informa Healthcare 10.1080/10428194.2019.1594213
Shumilov, Evgenii; Flach, Johanna; Joncourt, Raphael; Porret, Naomi; Wiedemann, Gertrud; Novak, Urban; Gfeller, Eva; Jeker, Barbara; Amstutz, Ursula; Pabst, Thomas; Bacher, Vera (2019). Clinical value of molecular MRD monitoring by next-generation sequencing in patients with IDH2 mutated AML. Leukemia & lymphoma, 60(10), pp. 2588-2590. Taylor & Francis 10.1080/10428194.2019.1585838
Hitz, F; Kraus, M; Pabst, Thomas; Hess, D; Besse, L; Silzle, T; Novak, Urban; Seipel, Katja; Rondeau, S; Stüdeli, S; Vilei, S Berardi; Samaras, P; Mey, U; Driessen, C (2019). Nelfinavir and lenalidomide/dexamethasone in patients with lenalidomide-refractory multiple myeloma. A phase I/II Trial (SAKK 39/10). Blood cancer journal, 9(9), p. 70. Springer Nature 10.1038/s41408-019-0228-2
Herbrand, Amanda; Schmitt, Andreas; Briel, Matthias; Diem, Stefan; Ewald, Hannah; Hoogkamer, Anouk; Joerger, Markus; Mc Cord, Kimberly; Novak, Urban; Sricharoenchai, Sirintip; Hemkens, Lars; Kasenda, Benjamin (29 July 2019). Contrasting Evidence to Reimbursement Reality for Off-label use 1 (OLU) of Drug Treatments in Cancer Care – Rationale and Design of 2 the CEIT-OLU-project (medRxiv). Cold Spring Harbor Laboratory 10.1101/19003152
Bachmann, Kaspar F.; Nebiker, Mathias; Johner, Caroline; Bregy, Rachel; Schaller, André; Novak, Urban; Jakob, Stephan M. (2019). Rare Case of Transcutaneous Oxygen Desaturation in a Cancer Patient: A Case Report and Diagnostic Approach for a Recurrent Problem. A&A practice, 12(4), pp. 96-98. Lippincott Williams & Wilkins 10.1213/XAA.0000000000000855
Amsler, Isabel G; Jeker, Barbara; Mansouri Taleghani, Behrouz; Bacher, Ulrike; Betticher, Daniel; Egger, Thomas; Zander, Thilo; Luethi, Jean-Marc; Novak, Urban; Pabst, Thomas (2019). Prolonged survival with increasing duration of lenalidomide maintenance after autologous transplant for multiple myeloma. Leukemia & lymphoma, 60(2), pp. 511-514. Taylor & Francis 10.1080/10428194.2018.1473577
Jeker, Barbara; Pabst Müller, Thomas Niklaus; Novak, Urban (2019). CAR-T-Zelltherapie – eine neue Behandlungsoption. Info@Onkologie, 2019(1), pp. 18-20. Aerzteverlag medinfo AG
Burkhard, Regula; Keller, Irene; Arambasic, Miroslav; Juskevicius, Darius; Tzankov, Alexandar; Lundberg, Pontus; Bruggmann, Rémy; Dirnhofer, Stephan; Radpour, Ramin; Novak, Urban (2019). TIRAP p.R81C is a novel lymphoma risk variant which enhances cell proliferation via NF-κB mediated signaling in B-cells. Haematologica - the hematology journal, 104(4), pp. 766-777. Ferrata-Storti Foundation 10.3324/haematol.2018.201590
Davies, Andrew; Cummin, Thomas E; Barrans, Sharon; Maishman, Tom; Mamot, Christoph; Novak, Urban; Caddy, Josh; Stanton, Louise; Kazmi-Stokes, Shamim; McMillan, Andrew; Fields, Paul; Pocock, Christopher; Collins, Graham P; Stephens, Richard; Cucco, Francesco; Clipson, Alexandra; Sha, Chulin; Tooze, Reuben; Care, Matthew A; Griffiths, Gareth; ... (2019). Gene-expression profiling of bortezomib added to standard chemoimmunotherapy for diffuse large B-cell lymphoma (REMoDL-B): an open-label, randomised, phase 3 trial. The lancet oncology, 20(5), pp. 649-662. Elsevier 10.1016/S1470-2045(18)30935-5
Shumilov, Evgenyi; Novak, Urban; Jeker, Barbara; Mansouri Taleghani, Behrouz; Bacher, Ulrike; Pabst, Thomas (2019). Hematopoietic Stem Cell Mobilization With Plerixafor Is Safe and Effective in Poorly Mobilizing Acute Myeloid Leukemia Patients. HemaSphere, 3(2), e176. Wolters Kluwer Health 10.1097/HS9.0000000000000176
Schnell, Bianca R.; Seipel, Katja; Bacher, Ulrike; Jeker, Barbara; Mueller, Beatrice U.; Banz, Yara; Novak, Urban; Pabst, Thomas (2019). Rebound Thrombocytosis after Induction Chemotherapy is a Strong Biomarker for Favorable Outcome in AML Patients. HemaSphere, 3(2), e180. Wolters Kluwer Health 10.1097/HS9.0000000000000180
Zucca, Emanuele; Rondeau, Stephanie; Vanazzi, Anna; Østenstad, Bjørn; Mey, Ulrich J. M.; Rauch, Daniel; Wahlin, Björn E.; Hitz, Felicitas; Hernberg, Micaela; Johansson, Ann-Sofie; de Nully Brown, Peter; Hagberg, Hans; Ferreri, Andrés J. M.; Lohri, Andreas; Novak, Urban; Zander, Thilo; Bersvendsen, Hanne; Bargetzi, Mario; Mingrone, Walter; Krasniqi, Fatime; ... (2019). Short regimen of rituximab plus lenalidomide in follicular lymphoma patients in need of first-line therapy. Blood, 134(4), pp. 353-362. American Society of Hematology 10.1182/blood-2018-10-879643
Herbrand, Amanda Katherina; Schmitt, Andreas Michael; Briel, Matthias; Diem, Stefan; Ewald, Hannah; Hoogkamer, Anouk; Joerger, Markus; Mc Cord, Kimberly Alba; Novak, Urban; Sricharoenchai, Sirintip; Hemkens, Lars G; Kasenda, Benjamin (2019). Contrasting evidence to reimbursement reality for off-label use (OLU) of drug treatments in cancer care: rationale and design of the CEIT-OLU project. ESMO open, 4(6), e000596. BMJ 10.1136/esmoopen-2019-000596
Novak, Urban (2019). Aggressive Lymphome & DLBCL – noch immer R-CHOP für alle? Leading Opinions. Hämatologie & Onkologie, 15(4), pp. 6-9. Universimed
Ferreri, Andres JM; Doorduijn, Jeanette K.; Cattaneo, Chiara; Cabras, Maria Giuseppina; Smith, Jeffery; Ilariucci, Fiorella; Narni, Franco; Calimeri, Teresa; Re, Alessandro; Khwaja, Jahanzaib; Botto, Barbara; Cellini, Claudia; Nassi, Luca; Linton, Kim; McKay, Pam; Olivieri, Jacopo; Patti, Caterina; Re, Francesca; Fanni, Alessandro; Singh, Vikram; ... (2019). Sequential Matrix-RICE Therapy Followed By Autologous Stem Cell Transplant in Patients with Diffuse Large B-Cell Lymphoma and Secondary Central Nervous System Involvement: The International Extranodal Lymphoma Study Group-42 Phase II (MARIETTA) Trial. Blood, 134(Suppl. 1), p. 353. American Society of Hematology 10.1182/blood-2019-129835
Conconi, Annarita; Zucca, Emanuele; Margiotta-Casaluci, Gloria; Darling, Katharine; Hasse, Barbara; Battegay, Manuel; Staehelin, Cornelia; Novak, Urban; Schmid, Patrick; Scherrer, Alexandra; Dirnhofer, Stephan; Kwee, Ivo; Nassi, Luca; Cavalli, Franco; Gaidano, Gianluca; Bertoni, Francesco; Bernasconi, Enos (2018). Population-based outcome analysis of diffuse large B-cell lymphoma in people living with HIV infection and competent individuals. Hematological oncology, 36(5), pp. 757-764. Wiley 10.1002/hon.2536
Moor, Ivana; Bacher, Vera Ulrike; Jeker, Barbara; Mansouri Taleghani, Behrouz; Mueller, Beatrice U; Keller, Heinz Peter; Betticher, Daniel; Egger, Thomas; Novak, Urban; Pabst, Thomas (2018). Peripheral flow-MRD status at the time of autologous stem cell collection predicts outcome in multiple myeloma. Bone marrow transplantation, 53(12), pp. 1599-1602. Nature Publishing Group 10.1038/s41409-018-0245-y
Bacher, Vera Ulrike; Shumilov, Evgenii; Flach, Johanna; Porret, Naomi; Joncourt, Raphael; Wiedemann, Gertrud; Fiedler, Martin; Novak, Urban; Amstutz, Ursula; Pabst, Thomas (2018). Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine use. Blood cancer journal, 8(11), p. 113. Nature Publishing Group 10.1038/s41408-018-0148-6
Driessen, Christoph; Müller, Rouven; Novak, Urban; Cantoni, Nathan; Betticher, Daniel; Mach, Nicolas; Rüfer, Axel; Mey, Ulrich; Samaras, Panagiotis; Ribi, Karin; Besse, Lenka; Besse, Andrej; Berset, Catherine; Rondeau, Stephanie; Hawle, Hanne; Hitz, Felicitas; Pabst Müller, Thomas Niklaus; Zander, Thilo (2018). Promising activity of nelfinavir-bortezomib-dexamethasone in proteasome inhibitor-refractory multiple myeloma. Blood, 132(19), pp. 2097-2100. American Society of Hematology 10.1182/blood-2018-05-851170
Farag, Sarah Ahmed Ibrahim; Jeker, Barbara; Bacher, Vera Ulrike; Mansouri Taleghani, Behrouz; Müller, Beatrice Ursula; Novak, Urban; Pabst Müller, Thomas Niklaus (2018). Dose-intensified bendamustine and melphalan (BenMel) conditioning before second autologous transplantation in myeloma patients. Hematological oncology, 36(4), pp. 671-678. Wiley 10.1002/hon.2546
Alva, Laura C; Bacher, Vera Ulrike; Seipel, Katja; Mansouri Taleghani, Behrouz; Mueller, Beatrice U; Novak, Urban; Pabst, Thomas (2018). Iron overload is correlated with impaired autologous stem cell mobilization and survival in acute myeloid leukemia. Transfusion, 58(10), pp. 2365-2373. Wiley-Blackwell 10.1111/trf.14895
Gössi, Ursina; Jeker, Barbara; Mansouri Taleghani, Behrouz; Bacher, Vera Ulrike; Novak, Urban; Betticher, Daniel; Egger, Thomas; Zander, Thilo; Pabst, Thomas (2018). Prolonged survival after second autologous transplantation and lenalidomide maintenance for salvage treatment of myeloma patients at first relapse after prior autograft. Hematological oncology, 36(2), pp. 436-444. Wiley 10.1002/hon.2490
Novak, Urban (2018). Erstlinientherapie beim diffusen grosszelligen B-Zell-Lymphom: personalisierte Therapie oder alles R-CHOP? Schweizer Zeitschrift für Onkologie, 4, pp. 22-25. Rosenfluh Publikationen AG
Jeker, Barbara; Novak, Urban; Mansouri Taleghani, Behrouz; Baerlocher, Gabriela M.; Seipel, K; Mueller, B U; Bigler, M; Betticher, D; Luethi, J-M; Farese, S; Ruefer, A; Pabst, Thomas (2018). NSAID treatment with meloxicam enhances peripheral stem cell mobilization in myeloma. Bone marrow transplantation, 53(2), pp. 175-179. Nature Publishing Group 10.1038/bmt.2017.234
Scherz, Amina; Kroll, J; Lössl, Kristina; Novak, Urban (2018). (De)Eskalierung bei der Behandlung des frühen Mammakarzinoms. Swiss Medical Forum, 28(25), pp. 526-531. EMH Swiss Medical Publishers 10.4414/smf.2017.03238
Bargetzi, Mario; Baumann, Reto; Cogliatti, Sergio; Dietrich, Pierre-Yves; Duchosal, Michel; Goede, Jeroen; Hitz, Felicitas; Konermann, Carolin; Lohri, Andreas; Mey, Ulrich; Novak, Urban; Papachristofilou, Alexandros; Stenner, Frank; Taverna, Christian; Zander, Thilo; Renner, Christoph (2018). Diagnosis and treatment of follicular lymphoma: an update. Swiss medical weekly, 148, w14635. EMH Schweizerischer Ärzteverlag 10.4414/smw.2018.14635
Cihoric, Nikola; Tsikkinis, Alexandros; Vlaskou Badra, Eugenia; Glatzer, Markus; Novak, Urban; Scherz, Amina; Shelan, Mohamed; Soldatovic, Ivan; Chittazhathu Kurian Kuruvilla, Yojena; Aebersold, Daniel; Lössl, Kristina (2017). Highly conformal combined radiotherapy with cisplatin and gemcitabine for treatment of loco-regionally advanced cervical cancer - a retrospective study. Radiation oncology, 12(1), p. 202. BioMed Central 10.1186/s13014-017-0938-1
Jegerlehner, Sabrina; Rauch, Andri; Novak, Urban (2017). Recurrent Inflammatory Flares in HIV-Infected Patients: Consider Castleman Disease! Journal of investigative medicine high impact case reports, 5(3), p. 2324709617725094. Sage 10.1177/2324709617725094
Lo Priore, Elia; Fliedner, Monica; Heverhagen, Johannes; Novak, Urban; Marschall, Jonas (2017). The role of a surveillance programme for introducing peripherally inserted central catheters: a 2-year observational study in an academic hospital. Swiss medical weekly, 147(w14441), w14441. EMH Schweizerischer Ärzteverlag 10.4414/smw.2017.14441
Blum, Veronika; Heini, A D; Novak, Urban; Mansouri Taleghani, Behrouz; Baerlocher, Gabriela M.; Leibundgut, Kurt; Seipel, K; Banz Wälti, Yara; Bargetzi, M; Pabst, Thomas (2017). Hematopoietic stem cell remobilization with vinorelbine and filgrastim in AML. Bone marrow transplantation, 52(5), pp. 786-788. Nature Publishing Group 10.1038/bmt.2017.2
Oberson, JS; Novak, Urban; Mansouri Taleghani, Behrouz; Baerlocher, Gabriela M.; Seipel, Katja; Mueller, BU; Leibundgut, Kurt; Zimmerli, Stefan; Pabst, Thomas (2017). Revisiting G-CSF Support for Hematologic Recovery after Autologous Transplantation in AML Patients. Annals of Hematology & Oncology, 4(5), p. 1148. Austin Publishing Group 10.26420/annhematoloncol.2017.1148
Pestalozzi, Bernhard C; Tausch, Christoph; Dedes, Konstantin J; Rochlitz, Christoph; Zimmermann, Stefan; von Moos, Roger; Winterhalder, Ralph; Ruhstaller, Thomas; Mueller, Andreas; Buser, Katharina; Borner, Markus; Novak, Urban; Nussbaum, Catrina Uhlmann; Seifert, Bettina; Bigler, Martin; Bize, Vincent; Vilei, Simona Berardi; Rageth, Christoph; Aebi, Stefan (2017). Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10). BMC cancer, 17(1), p. 265. BioMed Central 10.1186/s12885-017-3261-1
Heini, Alexander D; Berger, Martin Dave; Seipel, Katja; Mansouri Taleghani, Behrouz; Baerlocher, Gabriela M.; Leibundgut, Kurt; Banz Wälti, Yara; Novak, Urban; Pabst, Thomas (2017). Consolidation with autologous stem cell transplantation in first remission is safe and effective in AML patients above 65 years. Leukemia research, 53, pp. 28-34. Elsevier 10.1016/j.leukres.2016.12.001
Stettler, Jasmin; Novak, Urban; Baerlocher, Gabriela M.; Seipel, Katja; Mansouri Taleghani, Behrouz; Pabst, Thomas (2017). Autologous stem cell transplantation in elderly patients with multiple myeloma: evaluation of its safety and efficacy. Leukemia & lymphoma, 58(5), pp. 1076-1083. Informa Healthcare 10.1080/10428194.2016.1233542
Gilli, Stefanie; Novak, Urban; Mansouri Taleghani, Behrouz; Baerlocher, Gabriela M.; Leibundgut, Kurt; Banz Wälti, Yara; Zander, Thilo; Betticher, Daniel; Egger, Thomas; Rauch, Daniel; Pabst, Thomas (2017). BeEAM conditioning with bendamustine-replacing BCNU before autologous transplantation is safe and effective in lymphoma patients. Annals of hematology, 96(3), pp. 421-429. Springer 10.1007/s00277-016-2900-y
Suter, Thomas; Novak, Urban (2017). Kardiologie: Der Preis fürs Überleben – kardiovaskuläre Nebenwirkungen onkologischer Therapien. Swiss Medical Forum, 17(03), pp. 61-63. EMH Swiss Medical Publishers 10.4414/smf.2017.02860
Novak, Urban (2017). "Toys for boys?". Swiss Medical Forum, 17(05), p. 122. EMH Swiss Medical Publishers 10.4414/smf.2017.02894
Berger, Martin Dave; Branger, Giacomo; Klaeser, Bernd; Mansouri Taleghani, Behrouz; Novak, Urban; Banz Wälti, Yara; Müller, Beatrice Ursula; Pabst, Thomas (2016). Zevalin and BEAM (Z-BEAM) versus rituximab and BEAM (R-BEAM) conditioning chemotherapy prior to autologous stem cell transplantation in patients with mantle cell lymphoma. Hematological oncology, 34(3), pp. 133-139. Wiley 10.1002/hon.2197
Rohner, Eliane; Wyss, Natascha; Heg, Zina; Faralli, Zully; Mbulaiteye, Sam M; Novak, Urban; Zwahlen, Marcel; Egger, Matthias; Bohlius, Julia (2016). HIV and human herpesvirus 8 co-infection across the globe: Systematic review and meta-analysis. International journal of cancer, 138(1), pp. 45-54. Wiley-Blackwell 10.1002/ijc.29687
Juilland, M.; Gonzalez, M.; Erdmann, T.; Banz Wälti, Yara; Jevnikar, Z.; Hailfinger, S.; Tzankov, A.; Grau, M.; Lenz, G.; Novak, Urban; Thome, M. (2016). CARMA1- and MyD88-dependent activation of Jun/ATF-type AP-1 complexes is a hallmark of ABC diffuse large B-cell lymphomas. Blood, 127(14), pp. 1780-1789. American Society of Hematology 10.1182/blood-2015-07-655647
Keller, Sandra; Seipel, Katja; Novak, Urban; Mueller, Beatrice U; Mansouri Taleghani, Behrouz; Leibundgut, Kurt; Pabst, Thomas (2015). Neurotoxicity of stem cell mobilization chemotherapy with vinorelbine in myeloma patients after bortezomib treatment. Leukemia research, 39(7), pp. 786-792. Elsevier 10.1016/j.leukres.2015.03.015
Fricker, Michael Peter; Dubach, Patrick; Helbling, Arthur; Diamantis, E; Villiger, Peter; Novak, Urban (2015). Not all facial swellings are angioedemas! Journal of investigational allergology & clinical immunology, 25(2), pp. 146-147. Esmon Publicidad
Castillo, Jorge J; Bower, Mark; Brühlmann, Jérémy; Novak, Urban; Furrer, Hansjakob; Tanaka, Paula Y; Besson, Caroline; Montoto, Silvia; Cwynarski, Kate; Abramson, Jeremy S; Dalia, Samir; Bibas, Michele; Connors, Joseph M; Furman, Michael; Nguyen, Minh-Ly; Cooley, Timothy P; Beltran, Brady E; Collins, Jaime A; Vose, Julie M; Xicoy, Blanca; ... (2014). Prognostic factors for advanced-stage human immunodeficiency virus-associated classical Hodgkin lymphoma treated with doxorubicin, bleomycin, vinblastine, and dacarbazine plus combined antiretroviral therapy: A multi-institutional retrospective study. Cancer research, 121(3), pp. 423-431. American Association for Cancer Research AACR 10.1002/cncr.29066
Klenke, Frank M.; Wirtz, Christian; Banz Wälti, Yara; Keel, Marius; Klass, Natalie Désirée; Novak, Urban; Benneker, Lorin Michael (2014). Multiple myeloma-associated amyloidoma of the sacrum: case report and review of the literature. Global Spine Journal, 4(2), pp. 109-114. Thieme 10.1055/s-0033-1360724
Burkhard, Regula; Bhagat, Govind; Cogliatti, Sergio B; Rossi, Davide; Gaidano, Gianluca; Pasqualucci, Laura; Novak, Urban (2014). BCL2 mutation spectrum in B-cell non-Hodgkin lymphomas and patterns associated with evolution of follicular lymphoma. Hematological oncology, 33(1), pp. 23-30. Wiley 10.1002/hon.2132
Reber, Rebekka; Banz Wälti, Yara; Garamvölgyi, Esther; Perren, Aurel; Novak, Urban (2013). Determination of the molecular subtypes of diffuse large B-cell lymphomas using immunohistochemistry: a case series from the Inselspital, Bern, and a critical appraisal of this determination in Switzerland. Swiss medical weekly, 143, w13748. EMH Schweizerischer Ärzteverlag 10.4414/smw.2013.13748
Rinaldi, Andrea; Mian, Michael; Chigrinova, Ekaterina; Arcaini, Luca; Bhagat, Govind; Novak, Urban; Rancoita, Paola M. V.; De Campos, Cassio P.; Forconi, Francesco; Gascoyne, Randy D.; Facchetti, Fabio; Ponzoni, Maurilio; Govi, Silvia; Ferreri, Andrés J. M.; Mollejo, Manuela; Piris, Miguel A.; Baldini, Luca; Soulier, Jean; Thieblemont, Catherine; Canzonieri, Vincenzo; ... (2011). Genome-wide DNA profiling of marginal zone lymphomas identifies subtype-specific lesions with an impact on the clinical outcome. Blood, 117(5), pp. 1595-1604. Washington, D.C.: American Society of Hematology 10.1182/blood-2010-01-264275
Novak, Urban; Basso, Katia; Pasqualucci, Laura; Dalla-Favera, Riccardo; Bhagat, Govind (2011). Genomic analysis of non-splenic marginal zone lymphomas (MZL) indicates similarities between nodal and extranodal MZL and supports their derivation from memory B-cells. British journal of haematology, 155(3), pp. 362-5. Oxford: Wiley-Blackwell 10.1111/j.1365-2141.2011.08841.x
Reber, R; Chan, WC; Novak, U (2011). Assessing DLBCL subtypes by immunohistochemistry E-Letter in response to Gutierrez-Garcia et al. Blood(117: 4836-43) Washington, D.C.: American Society of Hematology
Novak, U; Pasqualucci, L; Dalla-Favera, R (2011). Molecular Biology of Lymphomas. In: DeVita, Vincent D.; Lawrence, Theodore S.; Rosenberg, Steven A. (eds.) CANCER: Principles & Practice of Oncology. Lippincott Williams & Wilkins
Novak, Urban (2010). [Molecular biology of malignant lymphomas for non-specialists]. Therapeutische Umschau, 67(10), pp. 501-4. Bern: Huber
Novak, U (2010). Molekularbiologie maligner Lymphome für den Nichtspezialisten. Therapeutische Umschau, pp. 501-4. Bern: Huber
Saito, Masumichi; Novak, Urban; Piovan, Erich; Basso, Katia; Sumazin, Pavel; Schneider, Christof; Crespo, Marta; Shen, Qiong; Bhagat, Govind; Califano, Andrea; Chadburn, Amy; Pasqualucci, Laura; Dalla-Favera, Riccardo (2009). BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma. Proceedings of the National Academy of Sciences of the United States of America - PNAS, 106(27), pp. 11294-9. Washington, D.C.: National Academy of Sciences NAS 10.1073/pnas.0903854106
Novak, Urban; Rinaldi, Andrea; Kwee, Ivo; Nandula, Subhadra V; Rancoita, Paola M V; Compagno, Mara; Cerri, Michaela; Rossi, Davide; Murty, Vundavalli V; Zucca, Emanuele; Gaidano, Gianluca; Dalla-Favera, Riccardo; Pasqualucci, Laura; Bhagat, Govind; Bertoni, Francesco (2009). The NF-{kappa}B negative regulator TNFAIP3 (A20) is inactivated by somatic mutations and genomic deletions in marginal zone lymphomas. Blood, 113(20), pp. 4918-21. Washington, D.C.: American Society of Hematology 10.1182/blood-2008-08-174110
Novak, Urban; Grob, T. J.; Baskaynak, G.; Peters, U. R.; Aebi, Stefan; Zwahlen, D.; Tschan, Mario; Kreuzer, K.-A.; Oppliger Leibundgut, Elisabeth; Cajot, J.-F.; Tobler, Andreas; Fey, Martin (2001). Overexpression of the p73 gene is a novel finding in high-risk B-cell chronic lymphocytic leukemia. Annals of oncology, 12(7), pp. 981-986. Oxford University Press 10.1023/A:1011153206003
